A one health nanotechnology approach to address antimicrobial resistance: state-of-the-art and strategic outlook

Abstract

Antimicrobial resistance (AMR) has emerged as a critical global health threat, driven by the rapid evolution and dissemination of resistance mechanisms among pathogens, and exacerbated by the interconnectedness of human, animal, and environmental health sectors. This review provides a comprehensive synthesis of the mechanisms underlying AMR including membrane permeability modification, efflux pumps, enzymatic inactivation, and target site modification while framing the crisis within the One Health perspective that emphasizes cross-sectoral collaboration and holistic strategies. The article systematically evaluates current approaches to combating AMR, such as novel drug discovery, combination therapies, bacteriophage-based interventions, antimicrobial adjuvants, and antimicrobial peptides, highlighting their respective strengths and limitations. The core of the review focuses on the advances in nanotechnology-based strategies, detailing the antimicrobial potential of diverse nanomaterials including chitosan, poly(lactic-co-glycolic acid) (PLGA) nanoparticles, liposomes, solid lipid nanoparticles, metal and metal ion nanoparticles (e.g., zinc oxide, silver, copper, gold, titanium, magnetic, cobalt), carbon dots, dendrimers, and hydrogels. Special attention is given to their mechanisms of action, efficacy against multidrug-resistant organisms, and applicability across human, veterinary, and environmental contexts. Moreover, the review addresses the limitations of nanotechnology-based approaches, such as nanoparticle cytotoxicity, the potential for nanoparticle-induced resistance, and the toxicological and ecological risks posed to One Health ecosystems. By critically appraising these challenges, the review identifies key research gaps and regulatory hurdles that must be overcome to enable the safe and effective clinical translation of nano-antimicrobials. The article concludes by outlining future prospects for the field, advocating for interdisciplinary research, responsible stewardship, and innovative policy frameworks to sustain the fight against AMR and protect global health.

Graphical abstract: A one health nanotechnology approach to address antimicrobial resistance: state-of-the-art and strategic outlook

Transparent peer review

To support increased transparency, we offer authors the option to publish the peer review history alongside their article.

View this article’s peer review history

Article information

Article type
Review Article
Submitted
14 May 2025
Accepted
03 Aug 2025
First published
05 Aug 2025
This article is Open Access
Creative Commons BY-NC license

Mater. Adv., 2025, Advance Article

A one health nanotechnology approach to address antimicrobial resistance: state-of-the-art and strategic outlook

A. Desai, S. Ghosh, S. Sankaranarayanan, D. Bhatia and A. K. Yadav, Mater. Adv., 2025, Advance Article , DOI: 10.1039/D5MA00487J

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements